<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0000939'>Osteoporosis</z:hpo> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) in older women are considered enormous public health burdens </plain></SENT>
<SENT sid="1" pm="."><plain>The effects of <z:hpo ids='HP_0000939'>osteoporosis</z:hpo> on the oncologic outcome of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> surgery are poorly understood </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated the use of the <z:hpo ids='HP_0000939'>Osteoporosis</z:hpo> Self-assessment Tool for Asians (OSTA) for predicting postoperative outcome in older women after receiving surgical treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIALS AND METHODS: The present single-institution retrospective study analyzed patients who had undergone surgery for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in 2002-2008 </plain></SENT>
<SENT sid="4" pm="."><plain>To characterize the major population of women with <z:hpo ids='HP_0000939'>osteoporosis</z:hpo>, which consists of postmenopausal women, only patients aged 50 years and older were analyzed </plain></SENT>
<SENT sid="5" pm="."><plain>Their OSTA scores were evaluated for correlations with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific survival after surgery for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> by performing univariate, multivariate, and survival analyses </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: During a 7-year period, 440 women were studied </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific mortality and overall mortality rate was 28.4% and 33.4%, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>The univariate analyses revealed that significant predictors of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific mortality after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> surgery were the International Union Against <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> (UICC) stage, OSTA category, histologic grading, <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e>, and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion depth </plain></SENT>
<SENT sid="9" pm="."><plain>After risk adjustment, the UICC stage and OSTA risk index were independent predictors of mortality </plain></SENT>
<SENT sid="10" pm="."><plain>A comparison of OSTA risk index among patients with different UICC stages showed that the accuracy of the index in predicting <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific survival after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> surgery was greatest for patients with stage II and III disease </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: The UICC stage and OSTA risk status showed independent positive associations with postoperative mortality in aged female patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Moreover, the OSTA index had a particularly strong association with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific mortality in patients with UICC stage II and III </plain></SENT>
</text></document>